Hepatitis C services at harm reduction centres in the European Union: a 28-country survey

Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the mem...

Full description

Bibliographic Details
Authors: Pericàs, Juan M.; Bromberg, Daniel J.; Ocampo, Denise; Schatz, Eberhard; Wawer, Iwona; Wysocki, Piotr; Safreed-Harmon, Kelly; Lazarus, Jeffrey V.
Format: Article
Status:Published version
Publication date:2019
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/135497
Online Access:https://hdl.handle.net/2445/135497
Access Level:Open access
Keyword:Hepatitis C
Països de la Unió Europea
European Union countries
_version_ 1878736591517646848
author Pericàs, Juan M.
author2 Bromberg, Daniel J.
Ocampo, Denise
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
Safreed-Harmon, Kelly
Lazarus, Jeffrey V.
author2_role author
author
author
author
author
author
author
author_browse Bromberg, Daniel J.
Lazarus, Jeffrey V.
Ocampo, Denise
Pericàs, Juan M.
Safreed-Harmon, Kelly
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
author_facet Pericàs, Juan M.
Bromberg, Daniel J.
Ocampo, Denise
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
Safreed-Harmon, Kelly
Lazarus, Jeffrey V.
author_role author
collection Recercat. Dipósit de la Recerca de Catalunya
description Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the member states of the European Union (EU). It aimed to determine service providers’ understanding of the current services in their respective countries and the barriers experienced by PWID in accessing HCV testing, care and treatment services in their country. Methods: In 2017, 38 purposively selected harm reduction service providers completed a 26-item Englishlanguage online survey addressing the availability, accessibility and funding of HCV services at harm reduction centres. HCV-related data and reported findings were extracted by country or by responding organization. Results: Responses were received from all EU member states. Respondents from 23 countries reported that HCV tests are offered by harm reduction services in their countries, and eight countries reported that addiction specialists in their countries are able to prescribe HCV therapy. Almost half of the respondents (45%) said that their respective organizations had established referral systems with centres providing HCV treatment. Conclusions: Not all EU member states have harm reduction services that provide HCV tests, and many do not have established referral systems with treatment providers. Moreover, the inability of addiction specialists to prescribe HCV treatment points to missed opportunities to make treatment more accessible. Further, discrepancies were noted between the available HCV services and stakeholders’ knowledge about their availability.
eu_rights_str_mv openAccess
format article
id ES_91c19176ef9eaf4261e71a0c9b61c04e
institution Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:recercat.cat:2445/135497
publishDate 2019
publishDateSort 2019
publisher BioMed Central
publisherStr BioMed Central
reponame_str Recercat. Dipósit de la Recerca de Catalunya
spelling Hepatitis C services at harm reduction centres in the European Union: a 28-country survey Pericàs, Juan M. Bromberg, Daniel J. Ocampo, Denise Schatz, Eberhard Wawer, Iwona Wysocki, Piotr Safreed-Harmon, Kelly Lazarus, Jeffrey V. Hepatitis C Països de la Unió Europea European Union countries Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the member states of the European Union (EU). It aimed to determine service providers’ understanding of the current services in their respective countries and the barriers experienced by PWID in accessing HCV testing, care and treatment services in their country. Methods: In 2017, 38 purposively selected harm reduction service providers completed a 26-item Englishlanguage online survey addressing the availability, accessibility and funding of HCV services at harm reduction centres. HCV-related data and reported findings were extracted by country or by responding organization. Results: Responses were received from all EU member states. Respondents from 23 countries reported that HCV tests are offered by harm reduction services in their countries, and eight countries reported that addiction specialists in their countries are able to prescribe HCV therapy. Almost half of the respondents (45%) said that their respective organizations had established referral systems with centres providing HCV treatment. Conclusions: Not all EU member states have harm reduction services that provide HCV tests, and many do not have established referral systems with treatment providers. Moreover, the inability of addiction specialists to prescribe HCV treatment points to missed opportunities to make treatment more accessible. Further, discrepancies were noted between the available HCV services and stakeholders’ knowledge about their availability. BioMed Central https://hdl.handle.net/2445/135497
spellingShingle Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
Pericàs, Juan M.
Hepatitis C
Països de la Unió Europea
European Union countries
status_str publishedVersion
title Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_full Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_fullStr Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_full_unstemmed Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_short Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_sort Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
topic Hepatitis C
Països de la Unió Europea
European Union countries
topic_facet Hepatitis C
Països de la Unió Europea
European Union countries
url https://hdl.handle.net/2445/135497